Trials / Completed
CompletedNCT03541759
Pain Management After Elective Shoulder Surgery
Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- AUVA Traumazentrum Vienna Site UKH Meidling · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydromorphone Hcl 4Mg Tab | Hydal retard 4Mg Tab 2 times after surgery as basic medication. Hydal retard 2.6Mg maximum 2 per 24h when NRS \> 5. |
| DRUG | Piritramide 15mg s.c. | Dipidolor 15mg s.c. 2 times after surgery as basic medication. Dipidolor 7.5mg s.c. maximum 2 per 24h when NRS \> 5. |
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2018-05-15
- Completion
- 2018-05-17
- First posted
- 2018-05-31
- Last updated
- 2018-06-01
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03541759. Inclusion in this directory is not an endorsement.